Congruence Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Congruence Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 19, 2026	Series B	$39.5M	Amplitude Ventures — Role not disclosedBDC Capital's Thrive Venture Fund — Role not disclosedDimension — Role not disclosedDriehaus Capital Management — Role not disclosedFonds de solidarité FTQ — Role not disclosedInvestissement Québec — Role not disclosedLumira Ventures — Role not disclosedOrbiMed — Role not disclosedSilver Arc — Role not disclosed

Investors

Amplitude VenturesSeries B BDC Capital's Thrive Venture FundSeries B DimensionSeries B Driehaus Capital ManagementSeries B Fonds de solidarité FTQSeries B Investissement QuébecSeries B Lumira VenturesSeries B OrbiMedSeries B Silver ArcSeries B

Coverage

Mar 19, 2026Congruence Therapeutics · Series B

Similar companies

De¹Building a Financial World Model trained on live market execution dataUndisclosed · Strategic

OwnerProvides an AI-powered technology and marketing platform for local businesses$240M · Series D

Warpify RoboticsBuilds robot productivity infrastructure for deployment, leasing and RaaS modelsUndisclosed · Seed+

Sources

congruencetx.com ↗